You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Patent: 5,238,576

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,238,576
Title: Ion exchange device for purifying water, process for manufacturing it and its use for removing nitrates and/or nitrates from water
Abstract:The present invention relates to an ion exchange device for purifying water by reducing the nitrite and/or nitrate content, consisting of at least one container with a basic anion exchanger in chloride and/or sulphate form arranged therein and at least one additional basic anion exchanger layer in hydroxyl form or a hydroxyl-group-containing layer, in which the anion exchanger layers are arranged one behind the other directly and/or with the interposition of an intermediate layer and the anion exchange layer(s) in chloride and/or sulphate form is/are arranged not as a mixture but in (a) separate layer(s). The chloride and/or sulphate containing layer is arranged near or beneath the inlet aperture, preferably beneath the filter layer and/or (in the direction of flow of the water) in front of the anion exchange layer in the form of hydroxyl or containing hydroxyl groups. This invention also relates to processes for manufacturing and for using the ion exchange device to remove nitrates and/or nitrates from water.
Inventor(s): Affonso; Alvaro (D-6380 Bad Homburg v.d.H., DE)
Application Number:07/663,904
Patent Claims:see list of patent claims

Details for Patent 5,238,576

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial 2010-08-24 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial 2010-08-24 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.